Symbiotic Capital
Los Angeles, Californiasymbcap.com
Overview
A global life science credit firm that provides lending solutions and non-dilutive capital to support the growth of established, late-stage companies across biotechnology, medical devices, diagnostics, tools, synthetic biology, and other healthcare subsectors. Affiliated with Bellco Capital, the firm was founded by Dr. Arie Belldegrun.
Portfolio Companies
4
Website
symbcap.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| TARGAN | Mar 2026 | Growth Equity | Lead |
| TARGAN | Dec 2025 | Growth Equity | Lead |
| Caresyntax | Aug 2024 | Series C Extension | - |
| Accelus | Jan 2024 | Debt | Lead |
| Cleveland Diagnostics | Jan 2024 | VC Round | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.